To learn more, visit drink-todo.com
Your physician reviews your history, contraindications, and possible side effects before prescribing and monitors you throughout treatment
Can microdosing GLP-1s be used alongside HRT or during perimenopause
Both human clinical trials and animal experiments demonstrated that peripheral or central GLP-1 and GLP-1 analogs suppress food intake and reduce body weight (Turton et al., 1996
These trials also demonstrated a significant reduction in C-Reactive Protein (CRP) levels, reinforcing the hypothesis that suppressing the pro-inflammatory state may yield substantial clinical benefits in this patient population
LY3437943, a Novel Triple Glucagon, GIP, and GLP-1 Receptor Agonist for Glycemic Control and Weight Loss: From Discovery to Clinical Proof of Concept